Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.35 USD | -1.12% | -1.41% | -29.61% |
03-06 | Piper Sandler Adjusts Price Target on Fulgent Genetics to $25 From $28, Maintains Neutral Rating | MT |
02-29 | UBS Adjusts Fulgent Genetics Price Target to $25 From $35, Maintains Neutral Rating | MT |
Business Summary
Number of employees: 1,184
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Laboratory Services
100.0
%
| - | - | 289 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
93.0
%
| 603 | 97.4 % | 269 | 93.0 % | -55.40% |
Foreign
7.0
%
| 16 | 2.6 % | 20 | 7.0 % | +27.91% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ming Hsieh
CEO | Chief Executive Officer | 68 | 12/05/16 |
James Xie
FOU | Founder | 58 | 12/05/16 |
Paul Kim
DFI | Director of Finance/CFO | 56 | 31/12/15 |
Doreen Ng
CMP | Compliance Officer | - | 30/09/20 |
Lawrence Weiss
CTO | Chief Tech/Sci/R&D Officer | 67 | 05/05/21 |
Harry Gao
CTO | Chief Tech/Sci/R&D Officer | 57 | 31/01/12 |
Jakub Sram
SAM | Sales & Marketing | - | 31/12/13 |
Ellen Tsui
HRO | Human Resources Officer | - | 31/03/18 |
Natalie Prescott
LAW | General Counsel | - | 02/05/22 |
Mary Jane Abalos
PRN | Corporate Officer/Principal | 50 | 30/06/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ming Hsieh
CEO | Chief Executive Officer | 68 | 12/05/16 |
Linda Marsh
BRD | Director/Board Member | 74 | 31/07/19 |
Regina Groves
BRD | Director/Board Member | 66 | 02/01/23 |
Michael Nohaile
BRD | Director/Board Member | 55 | 31/07/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 32,663,666 | 20,158,141 ( 61.71 %) | 2,763,000 ( 8.459 %) | 61.71 % |
Company contact information
Fulgent Genetics, Inc.
4399 Santa Anita Avenue
91731, El Monte
+626-350-0537
http://www.fulgentgenetics.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.61% | 608M | |
-17.86% | 8.35B | |
+39.49% | 3.58B | |
-38.71% | 2.46B | |
-8.06% | 2.47B | |
-7.96% | 2.36B | |
-13.97% | 1.78B | |
-19.73% | 1.53B | |
-40.78% | 1.21B | |
+8.32% | 1.12B |
- Stock Market
- Equities
- FLGT Stock
- Company Fulgent Genetics, Inc.